0415SP |
Chlorophacinone (Qualitative), Serum/Plasma |
0606U |
Cocaine and Metabolites Screen, Urine |
0921U |
Cadmium, Urine |
0930B |
Caffeine, Blood |
0930FL |
Caffeine, Fluid |
0930SP |
Caffeine, Serum/Plasma |
0930U |
Caffeine, Urine |
0960B |
Cannabinoids Panel, Blood |
0960FL |
Cannabinoids Panel, Fluid |
0960ME |
Cannabinoids Panel (Qualitative), Meconium |
0960SP |
Cannabinoids Panel, Serum/Plasma |
0960TI |
Cannabinoids Panel, Tissue |
0962B |
Cannabidiol, Blood |
0962SP |
Cannabidiol, Serum/Plasma |
0964U |
Cannabinoid Metabolite, Urine |
0966B |
Cannabis Plus Recent Use Markers, Blood |
0966SP |
Cannabis Plus Recent Use Markers, Serum/Plasma |
0970B |
Carbamazepine and Metabolite, Blood |
0970FL |
Carbamazepine and Metabolite, Fluid |
0970SP |
Carbamazepine and Metabolite, Serum/Plasma |
0970TI |
Carbamazepine and Metabolite, Tissue |
0971SP |
Carbamazepine and Metabolite - Free, Serum/Plasma |
0972SP |
Carbamazepine and Metabolite - Total/Free/Bound, Serum/Plasma |
0975SP |
Carbamazepine-10,11-Epoxide, Serum/Plasma |
0975U |
Carbamazepine-10,11-Epoxide, Urine |
0980SP |
Carbaryl and Metabolite, Serum/Plasma |
0995U |
Carbon Disulfide Exposure (TTCA), Urine |
1006B |
Carbon Monoxide - Iron Ratio Profile, Blood |
1006TI |
Carbon Monoxide - Iron Ratio Profile, Tissue |
1009B |
Carbon Monoxide Exposure, Blood |
1019B |
Carbrital Profile, Blood |
1019SP |
Carbrital Profile, Serum/Plasma |
1029SP |
CBD, Serum/Plasma |
1030B |
Carisoprodol and Metabolite, Blood |
1030FL |
Carisoprodol and Metabolite, Fluid |
1030SP |
Carisoprodol and Metabolite, Serum/Plasma |
1030U |
Carisoprodol and Metabolite, Urine |
1040B |
Cetirizine, Blood |
1040SP |
Cetirizine, Serum/Plasma |
1040U |
Cetirizine, Urine |
1050SP |
Chloramphenicol, Serum/Plasma |
1055B |
Celecoxib, Blood |
1055SP |
Celecoxib, Serum/Plasma |
1056B |
Cenobamate, Blood |
1056SP |
Cenobamate, Serum/Plasma |
1080B |
Chlordiazepoxide and Metabolite, Blood |
1080SP |
Chlordiazepoxide and Metabolite, Serum/Plasma |
1080U |
Chlordiazepoxide and Metabolite, Urine |
1111U |
Chlorobenzene Exposure (p-Chlorophenol), Urine |
1140B |
Chloroquine, Blood |
1140P |
Chloroquine, Plasma |
1140U |
Chloroquine, Urine |
1180B |
Chlorothiazide, Blood |
1180SP |
Chlorothiazide, Serum/Plasma |
1190B |
Chlorpheniramine, Blood |
1190SP |
Chlorpheniramine, Serum/Plasma |
1190U |
Chlorpheniramine, Urine |
1220SP |
Chlorpropamide, Serum/Plasma |
1250B |
Chlorthalidone, Blood |
1250SP |
Chlorthalidone, Serum/Plasma |
1255B |
Chlorzoxazone, Blood |
1255SP |
Chlorzoxazone, Serum/Plasma |
1261U |
Chromium, Urine |
1262B |
Cimetidine, Blood |
1262SP |
Cimetidine, Serum/Plasma |
1262U |
Cimetidine, Urine |
1267B |
Clobazam, Blood |
1267U |
Clobazam, Urine |
1269SP |
Clobazam and Metabolite, Serum/Plasma |
1270B |
Clonazepam and Metabolite, Blood |
1270FL |
Clonazepam and Metabolite, Fluid |
1270SP |
Clonazepam and Metabolite, Serum/Plasma |
1270TI |
Clonazepam and Metabolite, Tissue |
1270U |
Clonazepam and Metabolite, Urine |
1271B |
Clonazolam & 8-Aminoclonazolam, Blood |
1271SP |
Clonazolam & 8-Aminoclonazolam, Serum/Plasma |
1271U |
Clonazolam & 8-Aminoclonazolam (Qualitative), Urine |
1272B |
Citalopram, Blood |
1272FL |
Citalopram, Fluid |
1272SP |
Citalopram, Serum/Plasma |
1272TI |
Citalopram, Tissue |
1272U |
Citalopram, Urine |
1275B |
Clonidine, Blood |
1275SP |
Clonidine, Serum/Plasma |
1275U |
Clonidine, Urine |
1280U |
Clorazepate as Metabolite, Urine |
1287B |
Clozapine and Metabolite, Blood |
1287FL |
Clozapine and Metabolite, Fluid |
1287SP |
Clozapine and Metabolite, Serum/Plasma |
1287TI |
Clozapine and Metabolite, Tissue |
1287U |
Clozapine and Metabolite, Urine |
1300B |
Cocaine and Metabolites, Blood |
1300FL |
Cocaine and Metabolites, Fluid |
1300ME |
Cocaine and Metabolites (Qualitative), Meconium |
1300SP |
Cocaine and Metabolites, Serum/Plasma |
1300TI |
Cocaine and Metabolites, Tissue |
1300U |
Cocaine and Metabolites, Urine |
1303B |
Cocaine and Products Panel, Blood |
1303SP |
Cocaine and Products Panel, Serum/Plasma |
1303U |
Cocaine and Products Panel, Urine |
1306U |
Codeine - Total (Conjugated/Unconjugated) Screen, Urine |
1320B |
Colchicine, Blood |
1320SP |
Colchicine, Serum/Plasma |
1320TI |
Colchicine, Tissue |
1348U |
Creatinine, Urine Overview: Evaluate Extent of Urine Dilution or Concentration |
1380B |
Cyanide, Blood |
1405B |
Cyclobenzaprine, Blood |
1405FL |
Cyclobenzaprine, Fluid |
1405SP |
Cyclobenzaprine, Serum/Plasma |
1405TI |
Cyclobenzaprine, Tissue |
1405U |
Cyclobenzaprine, Urine |
1415B |
Cyclosporine, Blood |
2423B |
Comprehensive Volatiles Panel, Blood |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
4207B |
Canrenone (Spironolactone metabolite), Blood |
4207SP |
Canrenone (Spironolactone metabolite), Serum/Plasma |
8031U |
Child Drug Exposure Screen, Urine |
8661B |
Codeine and Metabolite - Free (Unconjugated), Blood |
8661SP |
Codeine and Metabolite - Free (Unconjugated), Serum/Plasma |
8661U |
Codeine and Metabolite - Total (Conjugated/Unconjugated), Urine |
8681B |
Chlorpromazine, Blood |
8707B |
Clomipramine and Metabolite, Blood |
8707SP |
Clomipramine and Metabolite, Serum/Plasma |
8893OF |
Cocaine and Metabolites (Qualitative), Oral Fluid (Saliva) |
9129B |
Carisoprodol and Metabolite Screen, Blood |
9129FL |
Carisoprodol and Metabolite Screen, Fluid |
9129SP |
Carisoprodol and Metabolite Screen, Serum/Plasma |
9139B |
Clonazepam and Metabolite Screen, Blood |
9139FL |
Clonazepam and Metabolite Screen, Fluid |
9139SP |
Clonazepam and Metabolite Screen, Serum/Plasma |
9139U |
Clonazepam and Metabolite Screen, Urine |
9142B |
Cyanide Screen, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9356U |
Cannabinoids Screen, Urine |